Related Experiment Video
Updated: May 16, 2026

Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory
Published on: July 10, 2018
Experimental determination of the oral bioavailability and bioaccessibility of lead particles
Elise Deshommes1, Robert Tardif, Marc Edwards
1Department of Chemistry, Université de Montréal, 2900, Édouard-Montpetit, Montréal, QC H3C 3A7, Canada. sebastien.sauve@umontreal.ca.
Abstract:
In vivo estimations of Pb particle bioavailability are costly and variable, because of the nature of animal assays. The most feasible alternative for increasing the number of investigations carried out on Pb particle bioavailability is in vitro testing. This testing method requires calibration using in vivo data on an adapted animal model, so that the results will be valid for childhood exposure assessment. Also, the test results must be reproducible within and between laboratories. The Relative Bioaccessibility Leaching Procedure, which is calibrated with in vivo data on soils, presents the highest degree of validation and simplicity. This method could be applied to Pb particles, including those in paint and dust, and those in drinking water systems, which although relevant, have been poorly investigated up to now for childhood exposure assessment.
More Related Videos
12:22Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
Published on: November 9, 2015
08:46Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
Published on: April 21, 2022
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability: Influencing Factors